| Literature DB >> 33921810 |
Majid Sharifi-Rad1, Pawel Pohl2, Francesco Epifano3.
Abstract
In the last years, the plant-mediated synthesis of nanoparticles has been extensively researched as an affordable and eco-friendly method. The current study confirms for the first time the capability of the Otostegia persica (Burm.) Boiss.Entities:
Keywords: Otostegia persica; medical application; phytofabrication; silver nanoparticle
Year: 2021 PMID: 33921810 PMCID: PMC8074182 DOI: 10.3390/nano11041045
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1The UV-Vis absorption spectra of the AgNPs phytofabricated by using the O. persica leaf extract and the color change of the reaction mixture due to the formation of the AgNPs at different reaction times.
Figure 2(A) The Fourier-transform infrared (FTIR) spectrum of the O. persica leaf extract () and the phytofabricated AgNPs (separated from the reaction mixture and cleaned with water) (); (B) The X -ray diffraction (XRD) pattern of the AgNPs phytofabricated by using the O. persica leaf extract.
Figure 3(A) The TEM image, and (B) the particles size distribution of the AgNPs phytofabricated by using the O. persica leaf extract.
Figure 4The zeta potential of the AgNPs phytofabricated by using the O. persica leaf extract.
Figure 5(A) The total phenolics and (B) the total flavonoids content of the O. persica leaf extract and the phytofabricated AgNPs.
Figure 6(A) The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity and (B) the 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging activity of the O. persica leaf extract and the phytofabricated AgNPs. Various letters denote significant differences among the treatments based on the Duncan’s test (p < 0.05).
The inhibition zone of the O. persica leaf extract and the phytofabricated AgNPs against Gram-positive and Gram-negative bacteria strains.
| Diameter of the Inhibition Zone (mm) | |||||||
|---|---|---|---|---|---|---|---|
| Concentration (µg/mL) |
|
|
|
|
|
| |
| Extract | 50 | 13 ± 0.5 Ka | 12 ± 0.4 Ib | 10 ± 0.4 Gc | 7 ± 0.2 Lf | 9 ± 0.2 Ld | 8 ± 0.1 Le |
| 100 | 15 ± 0.3 Ja | 13 ± 0.5 Hb | 12 ± 0.1 Fc | 9 ± 0.4 Kf | 11 ± 0.4 Kd | 10 ± 0.2 Ke | |
| 150 | 17 ± 0.1 Ha | 15 ± 0.3 Gb | 14 ± 0.2 Ec | 10 ± 0.4 Jf | 12 ± 0.3 Jd | 11 ± 0.3 Je | |
| 200 | 19 ± 0.2 Fa | 17 ± 0.2 Fb | 15 ± 0.6 Dc | 12 ± 0.5 If | 14 ± 0.5 Id | 13 ± 0.4 Ie | |
| 250 | 20 ± 0.3 Ea | 18 ± 0.2 Eb | 17 ± 0.2 Cc | 14 ± 0.2 Hf | 16 ± 0.2 Hd | 15 ± 0.2 He | |
| 300 | 22 ± 0.2 Ca | 19 ± 0.3 Db | 18 ± 0.3 Bc | 15 ± 0.3 Ge | 18 ± 0.3 Gc | 17 ± 0.5 Gd | |
| AgNPs | 50 | 15 ± 0.3 Jd | 13 ± 0.2 He | 12 ± 0.3 Ff | 16 ± 0.2 Fc | 19 ± 0.3 Fa | 17 ± 0.6 Gb |
| 100 | 16 ± 0.1 Id | 15 ± 0.3 Ge | 14 ± 0.4 Ef | 17 ± 0.1 Ec | 21 ± 0.5 Ea | 19 ± 0.4 Eb | |
| 150 | 18 ± 0.4 Gd | 17 ± 0.5 Fe | 15 ± 0.6 Df | 19 ± 0.3 Dc | 22 ± 0.2 Da | 20 ± 0.2 Db | |
| 200 | 20 ± 0.2 Ec | 18 ± 0.4 Ed | 17 ± 0.2 Ce | 21 ± 0.4 Cb | 23 ± 0.1 Ca | 21 ± 0.3 Cb | |
| 250 | 21 ± 0.5 Dd | 20 ± 0.2 Ce | 18 ± 0.1 Bf | 23 ± 0.2 Bc | 26 ± 0.1 Ba | 24 ± 0.2 Bb | |
| 300 | 23 ± 0.4 Bd | 21 ± 0.2 Be | 20 ± 0.1 Af | 25 ± 0.6 Ac | 28 ± 0.3 Aa | 26 ± 0.1 Ab | |
| Gentamicin (10 µg/disk) | 25 ± 0.2 Aa | 22 ± 0.1 Ab | 20 ± 0.5 Ac | 16 ± 0.2 Ff | 19 ± 0.4 Fd | 18 ± 0.2 Fe | |
Various uppercase letters show significant differences among different concentrations of the extract and the AgNPs, and various lowercase letters show significant differences among different bacteria at the same concentration (p < 0.05).
The minimum inhibitory concentrations (MIC) and the minimum bactericidal concentrations (MBC) of the O. persica leaf extract and the phytofabricated AgNPs against Gram-positive and Gram-negative bacteria.
| MIC (µg/mL) | MBC (µg/mL) | |||
|---|---|---|---|---|
| Bacteria strains | Extract | AgNPs | Extract | AgNPs |
|
| 75 | 37.5 | 150 | 75 |
|
| 75 | 37.5 | 150 | 75 |
|
| 75 | 37.5 | 150 | 75 |
|
| 150 | 18.75 | 300 | 37.5 |
|
| 150 | 9.4 | 300 | 18.75 |
|
| 150 | 9.4 | 300 | 18.75 |
Figure 7The antifungal activity of the O. persica leaf extract and the phytofabricated AgNPs.
Figure 8The anti-inflammatory activity of the O. persica leaf extract and the phytofabricated AgNPs. Various letters denote significant differences among the treatments based on the Duncan’s test (p < 0.05).